NSC |
Compound |
Enrichment |
Correlation |
NSC 750148 |
3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline |
0.00921214104936179 |
-0.20365171 |
NSC 756282 |
GW620972X |
0.00921214104936179 |
-0.11254854 |
NSC 761676 |
Null |
0.00921214104936179 |
0.05923778 |
NSC 80103 |
2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) |
0.00921214104936179 |
0.25775672 |
NSC 87086 |
Null |
0.00921214104936179 |
-0.052026723 |
NSC 625350 |
Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) |
0.00921214104936186 |
-0.32037904 |
NSC 639617 |
Null |
0.00921214104936186 |
0.52550115 |
NSC 691422 |
Acetonitrile, [11-(3,4-dimethoxyphenyl)-8,10-diphenyl- 8H,11H-pyrazolo[4',3':5,6]pyrano[3,2-e][1,2,4]-triazolo [1,5-c]pyrimidin-2-yl]- |
0.00921214104936186 |
-0.34864155 |
NSC 160121 |
1H,5H-Benzo[ij]quinolizine, 2,3,6,7-tetrahydro-9-(octylamino)-, dihydrochloride |
0.00921214104936192 |
0.27253426 |
NSC 287459 |
Cytarabine AY |
0.00921214104936192 |
0.24798389 |